Drugmakers Including Abbott Laboratories, Biogen Idec, Inc. (Massachusetts) and Merck & Co., Inc. Form Consortium

Published: Jun 21, 2012

Boston, MA— Massachusetts Governor Deval Patrick and the Massachusetts Life Sciences Center will join with seven global biopharma companies to announce a major new collaboration at the 2012 BIO International Convention on Wednesday, June 20th at 10:00 a.m. Abbott, Biogen Idec, EMD Serono, Janssen Research & Development, Merck, Pfizer and Sunovion Pharmaceuticals Inc. will join the announcement in the Massachusetts Pavilion (Booth #0137).

WHAT: Press Conference with Governor Deval Patrick, the Massachusetts Life Sciences Center, Abbott, Biogen Idec, EMD Serono, Janssen Research & Development, Merck, Pfizer and Sunovion to unveil a major new research collaboration.

WHEN: Wednesday, June 20, 2012, 10:00 a.m. Eastern Time

WHERE: The 2012 BIO International Convention at the Boston Convention & Exhibition Center, Massachusetts Pavilion (Pavilion #0137), 415 Summer Street, Boston, MA 02210


Distinguished speakers at the press conference will include:

• Gov. Deval Patrick, Commonwealth of Massachusetts

• James Hoyes, President, EMD Serono

• Jeffrey S. Flier, Dean of Harvard Medical School

• Susan Windham-Bannister, President & CEO, Massachusetts Life Sciences Center

• Patients representative of those potentially impacted by the research to be conducted through the new collaboration

Reporters interested in attending the press conference at the Boston Convention & Exhibition Center should register for media credentials at: http://testconvention.bio.org/media_registration/

About the Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a ten-year, $1 billion initiative that was signed into law in June of 2008. The Center’s mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties between sectors of the Massachusetts life sciences community. For more information, visit www.masslifesciences.com

Back to news